1-hexanol has been researched along with Carcinoma, Small Cell in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Caccuri, AM; Cianfriglia, M; Ciriolo, MR; Dupuis, ML; Federici, G; Filomeni, G; Forini, O; Pezzola, S; Turella, P | 1 |
1 other study(ies) available for 1-hexanol and Carcinoma, Small Cell
| Article | Year |
|---|---|
6-(7-Nitro-2,1,3-benzoxadiazol-4-ylthio)hexanol, a specific glutathione S-transferase inhibitor, overcomes the multidrug resistance (MDR)-associated protein 1-mediated MDR in small cell lung cancer.
Topics: Antineoplastic Agents; Apoptosis; ATP Binding Cassette Transporter, Subfamily B, Member 1; Carcinoma, Small Cell; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Enzyme Activation; Glutathione; Glutathione Transferase; Hexanols; Humans; JNK Mitogen-Activated Protein Kinases; Lung Neoplasms; Necrosis; Oxadiazoles; Oxidation-Reduction; p38 Mitogen-Activated Protein Kinases; Proto-Oncogene Proteins c-jun; Substrate Specificity | 2008 |